Skip to content

Digital Cognitive Behavioral Therapy (dCBT-I) for Maternal Insomnia

Digital Cognitive Behavioral Therapy (dCBT-I) for Maternal Insomnia During Pregnancy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05395546
Enrollment
200
Registered
2022-05-27
Start date
2022-06-01
Completion date
2023-06-01
Last updated
2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I)

Brief summary

Insomnia symptoms are common during pregnancy, especially in the second and third trimesters, which can reach more than 68%. Insomnia during pregnancy is not only associated with increased risk of preeclampsia, gestational diabetes, preterm labor, and cesarean section, but also increased postpartum poor sleep and postpartum depression. Cognitive behavioral therapy (CBT-I) and drug therapy for insomnia are the two main methods of insomnia treatment. Drug therapy is the more commonly used traditional treatment method, but there may be certain drug risks. Therefore, non-drug methods for Insomnia in pregnant women is much safer. Cognitive-behavioral therapy for insomnia is a psychological therapy for insomnia. Compared with sedative-hypnotic drugs, its therapeutic effect is slow, but the curative effect is long-lasting, with less relapse after treatment and no invasive side effects. Multiple guidelines recommend it as first-line therapy for insomnia. And Digital Cognitive Behavioral Therapy (dCBT-I), is based on CBT-I, a therapy provided by the Internet and smartphones, which simulates face-to-face CBT-I in reality. It can provide more convenient medical services for the special group of pregnant women, improve sleep, improve mental symptoms, life treatment, and reduce the risk of adverse outcomes for mothers and children. The Womens' Hospital, Zhejiang University School of Medicine is conducting a clinical study on Digital Cognitive Behavioral Therapy (dCBT-I) for maternal Insomnia during pregnancy. The primary goal of this research project was to examine the efficacy of dCBT-I (RuMian) in the treatment of maternal insomnia. RuMian is a fully automatic dCBT-I application developed in China, and subjects will use it for free.

Interventions

OTHERdCBT-I

1. Complete the evaluation of various scales and record a 7-day sleep diary before entering the group 2. Receive a 6-week treatment after enrollment, insist on using the app every day (about 5-10 minutes), and receive regular follow-up from the project doctor 3. Scale assessment needs to be completed at the end of treatment 4. One month after the end of treatment, cooperate with relevant follow-up and complete the scale evaluation

Sponsors

Women's Hospital School Of Medicine Zhejiang University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-40 years old * 20-32 weeks of pregnancy, singleton pregnancy and regular obstetric examination at Zhejiang University Women's Hospital * There has been a high frequency of insomnia symptoms * According to the preliminary assessment by the project team, it meets the diagnostic criteria for insomnia * Possess a smart phone and can operate it proficiently, with normal reading and writing comprehension ability, clear consciousness, and able to cooperate with the research to complete the questionnaire independently.

Exclusion criteria

* Assess the risk of preterm birth and concurrent pregnancy-related diseases; * Completion of the 7-day sleep diary in the baseline period \< 4 days; * Combined with severe anxiety/depression; * Suicidal tendencies or severe mental illness (bipolar disorder, schizophrenia, paranoid psychosis, etc.); * Edinburgh Pregnancy Depression Scale (EPDS) total score ≥ 15; * Have drug dependence or have taken anti-anxiety, anti-depression, sedative or hypnotic drugs for mental diseases within the past 3 months; * Participated in interventions such as meditation courses, childbirth yoga or cognitive behavioral therapy in the past 1 year; * Complicated with serious physical diseases such as heart failure and tumor; * Combined with sleep disorders such as severe obstructive sleep apnea that require further evaluation and treatment; * There is alcohol and cigarette dependence; * Shift work; * Severe visual or hearing impairment and unable to use mobile phones normally; * Physical illness with unstable condition, or illness itself that may interfere with cognitive behavioral therapy for insomnia.

Design outcomes

Primary

MeasureTime frameDescription
Change of Insomnia Severity Index(ISI)From before treatment to the end of treatment (an average of 42 days)Insomnia Severity Index(ISI),the minimum and maximum values are 0 and 28, and higher scores mean a worse outcome.

Secondary

MeasureTime frameDescription
Change of sleep onset latency(SOL)From before treatment to the end of treatment (an average of 42 days)simple questionnaire will be used to assess this outcome of sleep onset latency(SOL)
Change of wake up after sleep onset(WASO)From before treatment to the end of treatment (an average of 42 days)simple questionnaire will be used to assess this outcome of WASO
Change of sleep efficiency(SE)From before treatment to the end of treatment (an average of 42 days)combination of questionnaire and calculate will be used to assess this outcome of SE
Change of Pittsburgh Sleep Quality Index(PSQI)From before treatment to the end of treatment (an average of 42 days)Pittsburgh Sleep Quality Index(PSQI),the minimum and maximum values are 0 and 21, and higher scores mean a worse outcome.
Change of total sleep time(TST)From before treatment to the end of treatment (an average of 42 days)total sleep time(TST)
Change of Edinburgh Pregnancy Depression Scale(EPDS)From before treatment to the end of treatment (an average of 42 days)Edinburgh Pregnancy Depression Scale(EPDS),the minimum and maximum values are 0 and 30, and higher scores mean a worse outcome.
Change of Self-rating Anxiety Scale(SAS)From before treatment to the end of treatment (an average of 42 days)Self-rating Anxiety Scale(SAS), the minimum and maximum values are 25 and 100, and higher scores mean a worse outcome.
Change of Number of wake ups during the nightFrom before treatment to the end of treatment (an average of 42 days)Number of wake ups during the night

Contacts

Primary ContactZhaoxia Liang
xiaozaizai@zju.edu.cn+860571-87061501

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026